S03 Diabetes and the Skeleton

Program: Symposia
Basic/Translational Session
Thursday, March 5, 2015: 9:30 AM-11:00 AM
Room 29 (San Diego Convention Center)
**This session is eligible for CME credit**

David Ryan Weber, MD, MSCE, The Children's Hospital of Philadelphia, Philadelphia, PA

Nothing to Disclose: DRW Disclosure Not Provided: NN, MEK, TL, ALS

Diabetes and its treatments are associated with an increased risk of fractures. It has become apparent that impaired bone quality and not low bone density is the mechanism for increased fragility. This symposium will address the scope and mechanism of the problem.

9:30 AM
Ann V Schwartz, PhD, Epidemiology and Biostatistics, Univ of CA-San Francisco, San Francisco, CA
Nothing to Disclose: AVS
9:50 AM
Mary Larsen Bouxsein, PhD, Center for Advanced Orthopedic Studies, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
Nothing to Disclose: MLB
10:10 AM
Joshua Nicholas Farr, PhD, Endocrinology, Mayo Clinic, Rochester, MN
Nothing to Disclose: JNF
10:30 AM
Christian Meier, MD, Division of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, Switzerland
Nothing to Disclose: CM
See more of: Symposia